Cargando…
Genetic analysis of HLA, NA and HPA typing in type 2 diabetes and ASO
We examined the genetic status of human leucocyte antigens (HLA), human platelet alloantigens (HPA) and neutrophil-specific antigens (NA) in patients with type 2 diabetes mellitus and diabetic arteriosclerosis obliterans (ASO). To our knowledge, the present study is the first report showing the rela...
Autores principales: | Nomura, S, Shouzu, A, Omoto, S, Matsuzaki, T, Yamaoka, M, Abe, M, Hosokawa, M, Nishikawa, M, Iwasaka, T, Fukuhara, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464425/ https://www.ncbi.nlm.nih.gov/pubmed/16611256 http://dx.doi.org/10.1111/j.1744-313X.2006.00581.x |
Ejemplares similares
-
Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
por: Omoto, Seitaro, et al.
Publicado: (2015) -
Olivine-type NaCd(AsO(4))
por: Weil, Matthias
Publicado: (2013) -
Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus
por: Nomura, Shosaku, et al.
Publicado: (2011) -
Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)
por: Nomura, Shosaku, et al.
Publicado: (2018) -
Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus
por: Nomura, Shosaku, et al.
Publicado: (2023)